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http://www.biomedcentral.com/1471-2350/15/53RESEARCH ARTICLE Open AccessAllelic expression analysis of the osteoarthritis
susceptibility locus that maps to chromosome
3p21 reveals cis-acting eQTLs at GNL3 and SPCS1
Fiona Gee*, Clare F Clubbs, Emma VA Raine, Louise N Reynard and John LoughlinAbstract
Background: An osteoarthritis (OA) susceptibility locus has been mapped to chromosome 3p21, to a region of
high linkage disequilibrium encompassing twelve genes. Six of these genes are expressed in joint tissues and we
therefore assessed whether any of the six were subject to cis-acting regulatory polymorphisms active in these
tissues and which could therefore account for the association signal.
Methods: We measured allelic expression using pyrosequencing assays that can distinguish mRNA output from
each allele of a transcript single nucleotide polymorphism. We assessed RNA extracted from the cartilage and other
joint tissues of OA patients who had undergone elective joint replacement surgery. A two-tailed Mann–Whitney
exact test was used to test the significance of any allelic differences.
Results: GNL3 and SPCS1 demonstrated significant allelic expression imbalance (AEI) in OA cartilage (GNL3, mean
AEI = 1.04, p = 0.0002; SPCS1, mean AEI = 1.07, p < 0.0001). Similar results were observed in other tissues. Expression
of the OA-associated allele was lower than that of the non-associated allele for both genes.
Conclusions: cis-acting regulatory polymorphisms acting on GNL3 and SPCS1 contribute to the OA association
signal at chromosome 3p21, and these genes therefore merit further investigation.
Keywords: Osteoarthritis, Genetic risk, Single nucleotide polymorphism, Allelic imbalance, Linkage disequilibriumBackground
Osteoarthritis (OA) is a common disease of the synovial
joint characterised by progressive loss of articular cartilage
and often accompanied by changes to the normal function
of other tissues of the articulating joint [1]. Epidemio-
logical studies have demonstrated that the disease has a
major genetic component, consisting of a large number of
susceptibility alleles of small individual magnitude [2]. Re-
cently, several genome-wide association scans (GWAS)
have identified susceptibility loci for OA [3-5].
The UK arcOGEN GWAS identified five genome-wide
significant loci [3]. The most significant signal, at locus
3p21.1, was associated with hip and knee OA ascertained
by joint replacement surgery. This signal was marked by
two single nucleotide polymorphisms (SNPs) in perfect
linkage disequilibrium (LD; r2 = 1) with one another:* Correspondence: fiona.gee@newcastle.ac.uk
Institute of Cellular Medicine, Musculoskeletal Research Group, Newcastle
University, Newcastle-upon-Tyne, UK
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Commons Attribution License (http://creativec
reproduction in any medium, provided the or
Dedication waiver (http://creativecommons.or
unless otherwise stated.rs6976 (C/T) and rs11177 (C/T) (p = 7.24 × 10−11 and
1.25 × 10−10, respectively; odds ratio = 1.12 for the
minor alleles). rs6976 is located in the 3-untranslated region
(UTR) of GLT8D1, which codes for glycosyltransferase 8 do-
main containing 1, whilst rs11177 is a non-synonymous
SNP within exon 3 of GNL3, which codes for nucleoste-
min. The amino acid substitution coded for by rs11177 is
benign [3].
Most disease-associated alleles contribute to disease risk
by acting as expression quantitative trait loci (eQTLs), in-
fluencing the expression or stability of a transcript [6-8].
In OA an excellent example of this is rs143383, which is
located in the 5′ untranslated region (UTR) of GDF5; the
T allele of this SNP correlates with reduced GDF5 expres-
sion in the joint tissues of patients with OA [9]. We
hypothesised that the OA association of the 3p21.1 locus
may be due to an eQTL acting on one or more genes
within the LD block. We therefore assessed allelic expres-
sion of genes within the locus in joint tissue from OA. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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that can accurately distinguish the mRNA synthesised
from each allele of a gene.
Methods
Patients
The Newcastle and North Tyneside research ethics com-
mittee granted ethical approval (REC reference number
09/H0906/72) to obtain tissue from patients undergoing
elective hip replacement and knee replacement and in-
formed consent was obtained from each donor. Macro-
scopically normal articular cartilage away from the OA
lesion was obtained. Anterior cruciate ligament, fat pad,
synovium and meniscus were also obtained from a sub-
set of patients. Additional details regarding the 64 pa-
tients studied can be found in Additional file 1. Nucleic
acids were extracted from the tissues and cDNA synthe-
sized, as previously described [10,11].
Transcript SNP selection and genotyping
For GLT8D1 we used rs6976 whilst for GNL3 we used
rs11177. For each of the other genes studied we chose
where possible transcript SNPs that had the highest LD
with the association signal (Additional file 2). Genotypes
were determined by pyrosequencing.
Allelic expression analysis
Allelic expression imbalance (AEI) occurs when expres-
sion of a gene transcript is higher in the presence of one
allele of a SNP than the other. This can occur when the
polymorphism alters a transcription factor binding site
in a promoter or enhancer region, leading to preferential
binding of one or more transcription factors to one tran-
script compared to the other. We used pyrosequencing
to assess AEI for each gene of interest. Pyrosequencing
uses a proxy SNP within the gene transcript and entails
the quantitative sequencing of the region of DNA con-
taining the SNP to assess the relative amount of tran-
script produced from each allele [12]. When the proxy
SNP is in high or perfect LD with the association SNP,
the AEI results can be taken as a direct readout of
whether the association SNP correlates with differential
expression of the gene of interest. When the proxy SNP
is in low LD with the association SNP, the AEI results
for the proxy SNP must be stratified by genotype at the
association SNP in order to determine whether the asso-
ciation SNP correlates with differential expression of the
gene. If this is the case, no AEI will be seen in patients
homozygous for the association SNP, whereas AEI in
both directions will be observed in heterozygous pa-
tients. AEI that does not correlate with the assocation
SNP genotype is indicative of an independent eQTL cor-
relating with another SNP and unrelated to the associ-
ation signal.Standard PCR was performed to amplify the region
of interest and label the product with biotin. Primers
used (Sigma-Aldrich, Munich, Germany) are shown in
Additional file 3. PCR was performed using the G-Storm
GS-4 Q4 Quad Block Thermal Cycler (Somerton Biotech-
nology Centre, Somerton, UK) under the following cycling
conditions: 5 min at 95°C, 38 cycles of 95°C for 30 s, 54–
68°C for 30 s, and 72°C for 30 s, followed by 5 min at 72°C.
The 20 μl reaction mixture consisted of 25 ng DNA or
cDNA, 2 μl 10x PCR buffer, 1–2 mM MgCl2, 0.3 μM for-
ward primer, 0.3 μM reverse primer labelled with biotin at
the 5′-end, and 0.1U AmpliTaq Gold (Applied Biosystems,
Foster City, CA, USA). Samples were analysed on the Pyro-
Mark Q24 MDx platform (Qiagen GmbH, Nordrhein-
Westfallen, Germany) using the PyroMark Gold Q96
reagents Kit following manufacturer’s instructions. In
brief, the reverse primer was labelled with biotin at the 5′-
end (Sigma-Aldrich, Munich, Germany) and 20 μl of the
amplified DNA/cDNA product was mixed with 1.5 μl
Streptavidin Sepharose HP beads (Amersham Biosciences
AB, Sweden) and 40 μl binding buffer (10 mM Tris–HCl,
pH 7.6, 2 M NaCl, 1 mM EDTA, and 0.1% Tween-20),
followed by shaking at 2000 rpm for 10 min. The PCR
product-bead complex was captured using a vacuum
prep tool, then washed sequentially to remove the
non-biotinylated strand with 75% ethanol for 5 s,
0.2 M NaOH for 5 s and washing buffer (10 M Tris
acetate, pH 7.6) for 10 s. The beads were released into
25 μl annealing buffer containing 0.3 μM complemen-
tary sequencing primer (Sigma-Aldrich) and incubated at
80°C for 2 min. When cooled to room temperature the
mixture was loaded into the PyroMark platform with
assay-specific software to perform 10 cycles of ATCG dis-
penses. Sequences were generated automatically and an
output of allelic ratio produced using PSQ 96 SQA soft-
ware (Qiagen).
Samples were analysed in triplicate and only values
within one standard deviation from the mean were used.
Allelic expression of cDNA was normalised to its corre-
sponding DNA ratio. Accurate discrimination of SNP al-
leles was verified using artificially created allelic ratios
using DNA from homozygous samples.
Association with OA
We assessed transcript SNPs in NT5DC2 and POC1A for
evidence of association to OA using data from the arcO-
GEN study. This is a large genome-wide association scan
conducted in the UK on cases with severe OA of the hip
or knee, 80% of whom had undergone total joint replace-
ment, and on population controls [3]. The array used was
the Illumina 610 Quad array. Neither SNP is on the 610
Quad array used by arcOGEN, therefore proxy SNPs that
are on the array were used. For rs7639267 we used
rs10105543 (r2 = 0.902, D’ = 0.966) whilst for rs747343 we
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ies were all performed on OA cases who had undergone
total joint replacement, we assessed association using
those arcOGEN OA cases who had also undergone this
procedure. In total, we studied 5,804 arcOGEN OA cases
and 11,009 controls.
Results
The 3p21.1 association signal contains twelve genes in a
400 kb region [3]. The genes are STAB1, NT5DC2, PBRM1,
GNL3, GLT8D1, SPCS1, NEK4, ITIH1, ITIH3, ITIH4,
MUSTN1 and TMEM110. Previous targeted gene expres-
sion data by us demonstrated that NT5DC2, PBRM1,
GNL3, GLT8D1, SPCS1 and TMEM110 were all expressed
in cartilage from OA patients, the principal tissue involved
in the OA disease process [3 and unpublished observa-
tions]. We therefore focused on these genes.
We also wished to determine whether any genes outside
of but physically close to the 3p21.1 locus could be subject
to eQTLs that correlate with the rs6976 association signal;
such genes may be subject to distal-acting cis regulation
mediated by the signal. We searched the RegulomeDB
database for genes known to show differential expression
dependent on genotype at rs6976 [13]. This yielded an
eQTL at POC1A in lymphoblastoid cells. POC1A resides
telomeric to the association signal and codes for a centro-
somal protein. Missense mutations of the gene are
involved in the severe osteocutaneous disorder SOFT syn-
drome, in which growth of bone and ectodermal tissues is
arrested leading to a severe form of dwarfism [14]. We
demonstrated expression of POC1A in OA cartilage (data
not shown) and therefore included it with the six
cartilage-expressed genes that reside within the signal.
Interrogation of our previously published microarray
analysis of cartilage [15] revealed that GNL3 and SPCS1
were in the highest quartile of expressed genes, GLT8D1,
PBRM1, NT5DC2 and POC1A fell between the upper and
lower quartiles, and TMEM110 was within the lowest
quartile.
Allelic expression imbalance in cartilage
For each gene we identified individuals heterozygous for
the relevant transcript SNP and assayed the relative al-
lelic expression levels in cartilage samples. These sam-
ples included tissue from hip and knee joints, and for
those SNPs that demonstrated AEI, similar levels of im-
balance were detected in both hip and knee samples.
Additional file 2 lists the transcript SNPs used and their
pairwise r2 and D’ values relative to rs6976. If the
expression of a gene correlates with the association sig-
nal, and if the transcript SNP is in perfect (r2 = 1) or
complete (D’ = 1) LD with rs6976 we would expect to
observe AEI acting in only one direction. If the expres-
sion of a gene correlates with the association signal butthe transcript SNP is in low LD with rs6976, we would
expect AEI to act in both directions, but to correlate
with genotype at rs6976.GNL3, SPCS1, GLT8D1 and PBRM1
The transcript SNPs for three of these genes are in perfect
(GNL3) or complete (SPCS1 and PBRM1) LD with rs6976,
whilst for GLT8D1 the transcript SNP is rs6976. For GNL3
and SPCS1 we observed AEI in the same direction in the
vast majority of patients (Figure 1) and when the data for
each gene was combined across all patients (Figure 2) the
mean AEI was 1.04 for GNL3 (p = 0.0002) and 1.07 for
SPCS1 (p < 0.0001). This data implies that AEI at these two
genes correlates with the association signal. For GLT8D1
and PBRM1, AEI was observed in both directions (Figures 1
and 2; GLT8D1, mean AEI = 0.99, p = 0.0684; PBRM1,
mean AEI = 1.00, p = 0.2036), implying no correlation with
the association signal.NT5DC2, TMEM110 and POC1A
The transcript SNPs for these three genes are in low LD
with rs6976. For NT5DC2 and POC1A, we observed AEI in
the same direction for the majority of patients, whilst for
TMEM110 we observed AEI in both directions (Figures 1
and 2; NT5DC2, mean AEI = 0.84, p < 0.0001; POC1A,
mean AEI = 1.13, p = 0.0006; TMEM110, mean AEI = 0.97,
p = 0.01).
For each of these three genes, we plotted the allelic ra-
tios against genotype at rs6976 (Figure 3). No significant
correlations were identified (all p values > 0.05).
This implies that NT5DC2 and POC1A are subject to
eQTLs acting independently of the association SNP rs6976.
As the transcript SNPs within NT5DC2 and POC1A appear
to be subject to AEI that does not correlate with genotype
at rs6976, we assessed whether the eQTLs responsible for
the NT5DC2 and POC1A AEIs could also confer an altered
risk of OA. We tested the transcript SNPs rs7639267 and
rs747343 for association to OA using data previously gener-
ated by the arcOGEN GWAS [1]. No associations were ob-
served (both p values > 0.05; Additional file 4). Therefore,
the NT5DC2 and POC1A eQTLs are unlikely to contribute
to OA susceptibility.Allelic expression imbalance in other joint tissues
We extended our AEI analysis to include ligament, fat
pad, synovium and meniscus samples, all of which were
taken from knee joints. All seven genes showed compar-
able results in these tissues to their cartilage analyses
(Additional file 5), implying that the AEI effects observed
are active throughout the joint and not restricted to
cartilage.
A B
C D
E
G
F
Figure 1 Allelic expression analysis in cartilage samples from osteoarthritis (OA) patients. Allelic expression was assessed using the
transcript single nucleotide polymorphisms (SNPs) (A) rs11177, (B) rs6617, (C) rs17264436, (D) rs6976, (E) rs7639267, (F) rs6769789 and (G)
rs747343. Allelic expression of cDNA was normalised to its corresponding DNA. Data is presented as a ratio of expression of the major allele over
that of the minor allele; hence a value above 1 means that there is less of the OA-associated allele. Samples are grouped according to the
genotype at the OA-associated SNP rs6976, which are shown. Error bars represent the standard error of the mean.
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We performed allelic expression analysis of six genes
within and one gene close to the 3p21.1 OA association
signal. Whilst all seven genes displayed some degree of
AEI, our data indicate that only two correlate functionally
with OA susceptibility: GNL3 and SPCS1.
GLT8D1, PBRM1 and TMEM110 demonstrated varying
degrees of AEI in most individuals assayed, but there was
no correlation between AEI and genotype at rs6976.
NT5DC2 and POC1A demonstrated AEI in all individuals
assayed and the majority of imbalances operated in the
same direction, but again there was no correlation be-
tween AEI and genotype at rs6976. The arcOGEN GWAS[3] did not support association between OA and either
transcript SNP at NT5DC2 and POC1A. Overall therefore,
cis-regulation of these five genes does not appear to con-
tribute to the OA association signal marked by rs6976.
GNL3 and SPCS1 demonstrated AEI in the same direc-
tion in the vast majority of individuals assayed, with the
minor allele producing fewer transcripts than the major
allele. The fact that not all individuals showed AEI indi-
cates that the AEI at each gene may be modulated by a
SNP in high but not perfect LD with rs11177 (GNL3) and
rs6617 (SPCS1). For both genes, the AEI observed in car-
tilage was small in magnitude but highly significant and
was also observed in other joint tissues. As noted in the
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Figure 2 The proportion of the major allele of each SNP present in DNA and cDNA. Horizontal lines outside the box represent the smallest
and largest value; the horizontal line within the box represents the median value; the limits of the box represent the 25th and 75th percentiles.
p-values were calculated using a two-tailed Mann–Whitney exact test.
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array data of cartilage [15] revealed that GNL3 and SPCS1
were in the highest quartile of expressed genes. However,
in this data set neither gene demonstrated a diffence in ex-
pression between OA cartilage and cartilage from non-OA
controls. Since AEI directly compares the output from
one allele against another it is a more sensitive means of
assessing the existence of an eQTL than a microarrayanalysis. This may account for the absence of an apparent
difference in expression of GNL3 and SPCS1 between OA
and non-OA cartilage in our microarray data.
In this study we have confined our allelic expression
analyses to tissue from OA patients. However, we would
expect to see similar results if we were to analyse tissue
from healthy patients; the allelic expression imbalance ob-
served for GNL3 and SPCS1 would be expected to act in
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Figure 3 Columnar scatter plot of allelic ratios in cartilage cDNA stratified by genotype at rs6976. Allelic ratios of (A) rs7639267, (B)
rs6769789 and (C) rs747343 are shown. n is the number of patients studied for each group. Error bars in each plot represent the mean and the
standard error of the mean. The dashed horizontal lines in each plot show an allelic ratio of 1. p-values were calculated using a two-tailed
Mann–Whitney exact test for (A) and a Kruskal-Wallis test for (B) and (C).
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rs6976 leading to lower expression of each gene. However,
those individuals in possession of one or more copies of
the minor allele of rs6976 would experience an increased
risk of developing OA due to lower levels of each gene
transcript. A non-OA individual may carry copies of the
risk allele but will not develop the disease if they lack risk
alleles at other loci; the standard polygenic model.
rs11177 and rs6617 are in high LD (r2 = 0.932, D’ = 1),
such that the minor alleles for both SNPs are inherited to-
gether in a haplotype that correlates tightly with the asso-
ciation signal. Furthermore, the genes are transcribed in
the same direction. It appears possible therefore that they
are coordinately regulated by a common, polymorphic
regulatory element. Functionally, although the association
signal correlates with only a small decrease in expression
of each gene, the combined effect of lower expression of
both genes may contribute to the increased risk of devel-
oping OA that maps to this region of the genome.
Conclusions
In summary, our study reveals that GNL3 and SPCS1 are
subject to cis-acting polymorphisms that influence theexpression of the genes in the joint tissues of OA patients,
and that this regulation may account for the OA association
signal at 3p21.1. GNL3 codes for nucleostemin, a protein
involved in the regulation of the cell cycle and of cell prolif-
eration and self-renewal [16]. It also has a broader role in
maintaining nucleolar structure and telomerase activity
[17]. OA is characterised by an inability to maintain cartil-
age tissue and this may be the route through which the
reduced expression of GNL3 is acting to increase OA sus-
ceptibility, either on chondrocyte progenitors or on the ma-
ture chondrocytes themselves. SPCS1 codes for signal
peptidase complex subunit 1, for which very little is cur-
rently known. It is therefore difficult to speculate at this
stage as to how reduced expression of SPCS1 could contrib-
ute to OA risk. In order to elucidate how these genes con-
tribute to OA risk a number of molecular investigations
could be undertaken. These could include assessment of
possible enhancer activity of SNPs in high or perfect LD
with rs6976, using a luciferase-based assay in transformed
cell lines, and assessment of differential transcription factor
binding at such SNPs using electrophoretic mobility shift
assays. It would also be informative to assess the effects of
GNL3 and SPCS1 knockdown on the expression of a panel
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using articular chondrocytes and mesenchymal stem cells
undergoing chondrogenesis.
Overall, our results justify detailed investigation of these
two genes, and of their encoded proteins, in the context of
OA etiology.
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